首页> 外文期刊>Bioinformatics >Detection of potential enzyme targets by metabolic modelling and optimization: Application to a simple enzymopathy
【24h】

Detection of potential enzyme targets by metabolic modelling and optimization: Application to a simple enzymopathy

机译:通过代谢建模和优化检测潜在的酶靶标:应用于简单的酶病

获取原文
获取原文并翻译 | 示例
       

摘要

Motivation: A very promising approach in drug discovery involves the integration of available biomedical data through mathematical modelling and data mining. We have developed a method called optimization program for drug discovery (OPDD) that allows new enzyme targets to be identified in enzymopathies through the integration of metabolic models and biomedical data in a mathematical optimization program. The method involves four steps: (i) collection of the necessary information about the metabolic system and disease; (ii) translation of the information into mathematical terms; (iii) computation of the optimization programs prioritizing the solutions that propose the inhibition of a reduced number of enzymes and (iv) application of additional biomedical criteria to select and classify the solutions. Each solution consists of a set of predicted values for metabolites, initial substrates and enzyme activities, which describe a biologically acceptable steady state of the system that shifts the pathologic state towards a healthy state. Results: The OPDD was used to detect target enzymes in an enzymopathy, the human hyperuricemia. An existing S-system model and bibliographic information about the disease were used. The method detected six single-target enzyme solutions involving dietary modification, one of them coinciding with the conventional clinical treatment using allopurinol. The OPDD detected a large number of possible solutions involving two enzyme targets. All except one contained one of the previously detected six enzyme targets. The purpose of this work was not to obtain solutions for direct clinical implementation but to illustrate how increasing levels of biomedical information can be integrated together with mathematical models in drug discovery. Contact: julio.verna@informatik.uni-rostock.deorjulio_vera_g@yahoo.es Supplementary information: Supplementary data are available at Bioinformatics online.
机译:动机:药物开发中非常有前途的方法涉及通过数学建模和数据挖掘来整合可用的生物医学数据。我们已经开发了一种称为药物发现优化程序(OPDD)的方法,该方法允许通过在数学优化程序中集成代谢模型和生物医学数据,在酶促病中识别新的酶靶标。该方法包括四个步骤:(i)收集有关代谢系统和疾病的必要信息; (ii)将信息翻译成数学术语; (iii)优化程序的计算优先考虑建议抑制减少数量酶的解决方案,以及(iv)应用其他生物医学标准来选择和分类解决方案。每种溶液均由一组代谢物,初始底物和酶活性的预测值组成,这些预测值描述了系统的生物学上可接受的稳定状态,该状态将病理状态转变为健康状态。结果:OPDD用于检测一种酶病(人类高尿酸血症)中的目标酶。使用了现有的S系统模型和有关该疾病的书目信息。该方法检测了六种涉及饮食改良的单目标酶溶液,其中一种与使用别嘌呤醇的常规临床治疗相吻合。 OPDD检测到大量可能的溶液,其中涉及两个酶标靶。除一个外,所有均包含先前检测到的六个酶标靶之一。这项工作的目的不是要获得直接用于临床的解决方案,而是要说明如何在药物发现中将越来越多的生物医学信息与数学模型整合在一起。联系人:julio.verna @ informatik.uni-rostock.deorjulio_vera_g @ yahoo.es补充信息:补充数据可在在线生物信息学中获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号